nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adenylyl cyclase signalling complexes – Pharmacological challenges and opportunities
|
Halls, Michelle L. |
|
2017 |
172 |
C |
p. 171-180 |
artikel |
2 |
Allopurinol as a therapeutic option in cardiovascular disease
|
Okafor, Osita N |
|
2017 |
172 |
C |
p. 139-150 |
artikel |
3 |
Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
|
Faria, Alyssa |
|
2017 |
172 |
C |
p. 50-62 |
artikel |
4 |
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets
|
Deshpande, Deepak A. |
|
2017 |
172 |
C |
p. 116-126 |
artikel |
5 |
Complement: A primer for the coming therapeutic revolution
|
Barnum, Scott R. |
|
2017 |
172 |
C |
p. 63-72 |
artikel |
6 |
Current and novel insights into the neurophysiology of migraine and its implications for therapeutics
|
Akerman, Simon |
|
2017 |
172 |
C |
p. 151-170 |
artikel |
7 |
Human presynaptic receptors
|
Schlicker, Eberhard |
|
2017 |
172 |
C |
p. 1-21 |
artikel |
8 |
Maximising the potential of AKT inhibitors as anti-cancer treatments
|
Brown, Jessica S. |
|
2017 |
172 |
C |
p. 101-115 |
artikel |
9 |
MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction
|
Nassar, Farah J |
|
2017 |
172 |
C |
p. 34-49 |
artikel |
10 |
NaV1.7 as a pain target – From gene to pharmacology
|
Vetter, Irina |
|
2017 |
172 |
C |
p. 73-100 |
artikel |
11 |
Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders
|
Hasegawa, Masato |
|
2017 |
172 |
C |
p. 22-33 |
artikel |
12 |
The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance
|
Qiu, Guan-Zhong |
|
2017 |
172 |
C |
p. 127-138 |
artikel |
13 |
Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury
|
Carr, Daniel F. |
|
2017 |
172 |
C |
p. 181-194 |
artikel |